Indeed, anti-PD1-DAP10 CAR harnessed NKG2D signaling through the DAP10 domains and was shown to potentiate NK cell activation against PD1 and NKG2D ligand-expressing tumor cells [74]. The gene discussed is KLRK1; the disease is neoplasm.